- Coordinator
- Universitat De Valencia, Spain
- Runs
- 1 December 2023 to 30 November 2026
- Status
- Running
- EU funding
- €4.0m
- Total cost
- €4.0m
- Partners
- 7 organisations in 3 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101136516
What the project is doing
In the project's own words, from its summary on CORDIS.
NCDs, especially diabetes and cardiovascular diseases (CVDs), are the leading causes of morbidity and mortality worldwide. CVDs kill more people globally than any other disease, accounting for 17.9 million deaths per year. Diabetes, on the other hand, accounts for 2 million deaths annually. These diseases have a greater impact on vulnerable populations. This increased prevalence among this population is related to a range of social and environmental factors, lifestyles, and the impact of behavioural determinants.
Low-income communities, such as migrants or ethnic minorities, are still undertreated and unprotected by most of the healthcare systems with a lack of quality of care for NCDs and a lack of preventive measures specifically adapted for them. Thus, HORUS aims to tackle NCDs, especially diabetes and CVDs, in urban built environments among vulnerable populations, mainly low-income communities, migrants and ethnic minorities.
In particular, it has a twofold objective. (1) First, to analyse and explore in depth the causal links between the characteristics of the urban built environment and the prevalence of NCD risk behaviours in an integrated, comprehensive and multi-approach manner. HORUS will focus on existing urban interventions modifying the physical-social and functional characteristics of the built environment with a significant impact on the prevalence of risk behaviours and, eventually, NCD outcomes. (2) And, secondly, to develop pilot interventions in three European countries –Spain, Croatia and The Netherlands– to promote behaviour change towards healthier lifestyles for empowering vulnerable populations, and to support citizens in making optimal use of the urban environment they live in while reducing NCD risk behaviours, especially those related to diabetes and CVDs.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitat De Valencia | Valencia | Spain | Coordinator |
| Bax Innovation Consulting SL | Barcelona | Spain | Participant |
| Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana | Valencia | Spain | Participant |
| Senior Europa Sociedad Limitada | Ontinyent | Spain | Participant |
| Universitat Politecnica De Valencia | Valencia | Spain | Participant |
| Sveuciliste U Rijeci, Medicinski Fakultet | Rijeka | Croatia | Participant |
| Erasmus Universitair Medisch Centrum Rotterdam | Rotterdam | Netherlands | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI